Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity
RecruitingOBSERVATIONAL
Enrollment
200
Participants
Timeline
Start Date
July 17, 2025
Primary Completion Date
August 1, 2035
Study Completion Date
August 1, 2036
Conditions
Prostate Cancer (CRPC)
Trial Locations (1)
90095
RECRUITING
University of California at Los Angeles, Los Angeles
All Listed Sponsors
lead
Jonsson Comprehensive Cancer Center
OTHER
NCT07077239 - Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity | Biotech Hunter | Biotech Hunter